|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/4162 | |||
| A61P 9/00 |
| (11) | Number of the document | 2958914 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14705337.5 |
| Date of filing the European patent application | 2014-02-18 | |
| (97) | Date of publication of the European application | 2015-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/053096 |
| Date | 2014-02-18 |
| (87) | Number | WO 2014/128109 |
| Date | 2014-08-28 |
| (30) | Number | Date | Country code |
| 2806895 | 2013-02-21 | CA | |
| 2807859 | 2013-02-21 | CA |
| (72) |
KEIL, Birgit, DE
MAIS, Franz-Josef, DE
JOENTGEN, Winfried, DE
GRUNENBERG, Alfons, DE
|
| (73) |
Adverio Pharma GmbH,
Willy-Brandt-Platz 2, 12529 Schönefeld,
DE
|
| (54) | FORMS OF METHYL {4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDINO-3-YL]PYRIMIDINO-5-YL}METHYL CARBAMATE |
| FORMS OF METHYL {4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDINO-3-YL]PYRIMIDINO-5-YL}METHYL CARBAMATE |